or Try an Advanced Search...

    Neurological Disorders Stocks List

    Symbol Grade Name % Change
    FLGT F Fulgent Genetics, Inc. 1.74
    VAXX F Vaxxinity, Inc. -90.00
    IONS F Ionis Pharmaceuticals, Inc. 0.06
    NLSP F NLS Pharmaceutics Ltd. -2.45
    AEMD F Aethlon Medical, Inc. 0.13
    AIFF F Firefly Neuroscience, Inc. 2.33
    ADXN F Addex Therapeutics Ltd 0.76
    PMN F ProMIS Neurosciences Inc. -2.94
    PRTA F Prothena Corporation plc 4.00
    RLMD F Relmada Therapeutics, Inc. -1.32
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices Scientific & Technical Instruments
    Related Stock Lists: Biology Dementia Urological Disorders Alzheimer's Disease Biotechnology Cancer Disease Lewy Body Dementia Parkinson's Disease Adhd Alpha Synuclein Amphetamine Amyloid Amyloidosis Amyotrophic Lateral Sclerosis Attention Deficit Hyperactivity Disorder Biopharmaceutical Genetics Medicine Methylphenidate

    Related ETFs - A few ETFs which own one or more of the above listed Neurological Disorders stocks.

    Symbol Grade Name Weight
    PSIL C AdvisorShares Psychedelics ETF 4.48
    ARKG F ARK Genomic Revolution Multi-Sector ETF 3.85
    MNTL F Tema Neuroscience and Mental Health ETF 3.69
    MEDX F Horizon Kinetics Medical ETF 2.78
    HRTS D Tema Cardiovascular and Metabolic ETF 2.42
    View all Neurological Disorders ETFs...
    Compare ETFs
    Compare ARKG to MEDX Compare MNTL to HRTS Compare MNTL to MEDX

        Neurological Disorders Stocks Recent News

        Date Stock Title
        Nov 20 FLGT Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now
        Nov 20 IONS Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 RLMD Relmada Therapeutics to Present at Jefferies London Healthcare Conference
        Nov 18 IONS Here's Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks
        Nov 18 NLSP NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
        Nov 16 AIFF Firefly Neuroscience Third Quarter 2024 Earnings: US$0.61 loss per share (vs US$0.18 loss in 3Q 2023)
        Nov 15 AIFF Firefly Neuroscience reports Q3 results
        Nov 15 PRTA Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe
        Nov 14 AIFF Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
        Nov 14 PMN ProMIS Neurosciences GAAP EPS of $0.31 beats by $0.38
        Nov 14 PMN ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
        Nov 14 AEMD AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment Measures
        Nov 14 AEMD Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally
        Nov 14 RLMD Relmada Therapeutics Initiates Phase 1 Dosing with REL-P11 for Metabolic Disease
        Nov 14 AEMD Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ...
        Nov 14 AEMD Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript
        Nov 13 AEMD Aethlon Medical GAAP EPS of -$0.20 in-line
        Nov 13 AEMD Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
        Nov 13 PRTA Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices Scientific & Technical Instruments
        Related Stock Lists: Biology Dementia Urological Disorders Alzheimer's Disease Biotechnology Cancer Disease Lewy Body Dementia Parkinson's Disease Adhd Alpha Synuclein Amphetamine Amyloid Amyloidosis Amyotrophic Lateral Sclerosis Attention Deficit Hyperactivity Disorder Biopharmaceutical Genetics Medicine Methylphenidate
        Neurological Disorders

        Neurological disorders are conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. These disorders can affect how the body functions, including movement, speech, and memory. Examples of neurological disorders include Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, epilepsy, and migraine.

        Browse All Tags